Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010). Structure and function of the blood-brain barrier. Neurobiology of Disease, 37(1), 13–25. https://doi.org/10.1016/j.nbd.2009.07.030
Boado, R. J., Zhang, Y., Wang, Y., & Pardridge, W. M. (2009). Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse. Biotechnology and Bioengineering, 102(4), 1251–1258. https://doi.org/10.1002/bit.22135
Burek, M., Steinberg, K., & Förster, C. Y. (2014). Mechanisms of transcriptional activation of the mouse claudin-5 promoter by estrogen receptor alpha and beta. Molecular and Cellular Endocrinology, 392(1–2), 144–151. https://doi.org/10.1016/j.mce.2014.05.003
Englund, H., Sehlin, D., Johansson, A.-S., Nilsson, L. N. G., Gellerfors, P., Paulie, S., Lannfelt, L., & Pettersson, F. E. (2007). Sensitive ELISA detection of amyloid-beta protofibrils in biological samples. Journal of Neurochemistry, 103(1), 334–345. https://doi.org/10.1111/j.1471-4159.2007.04759.x
European Parliament. (2010). DIRECTIVE 2010/63/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 22 September 2010 on the protection of animals used for scientific purposes (Text with EEA relevance). Official Journal of the European Union, 33–79.
Fang, X. T., Hultqvist, G., Meier, S. R., Antoni, G., Sehlin, D., & Syvänen, S. (2019). High detection sensitivity with antibody-based PET radioligand for amyloid beta in brain. NeuroImage, 184(June 2018), 881–888. https://doi.org/10.1016/j.neuroimage.2018.10.011
Fang, X. T., Sehlin, D., Lannfelt, L., Syvänen, S., & Hultqvist, G. (2017). Efficient and inexpensive transient expression of multispecific multivalent antibodies in Expi293 cells. Biological Procedures Online, 19(1), 1–9. https://doi.org/10.1186/s12575-017-0060-7
Förster, C., Silwedel, C., Golenhofen, N., Burek, M., Kietz, S., Mankertz, J., & Drenckhahn, D. (2005). Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system. The Journal of Physiology, 565(2), 475–486. https://doi.org/10.1113/jphysiol.2005.084038
Helms, H. C., Abbott, N. J., Burek, M., Cecchelli, R., Couraud, P. O., Deli, M. A., Förster, C., Galla, H. J., Romero, I. A., Shusta, E. V., Stebbins, M. J., Vandenhaute, E., Weksler, B., & Brodin, B. (2015). In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use. Journal of Cerebral Blood Flow and Metabolism, 36(5), 862–890. https://doi.org/10.1177/0271678X16630991
Hultqvist, G., Syvänen, S., Fang, X. T., Lannfelt, L., & Sehlin, D. (2017). Bivalent brain shuttle increases antibody uptake by monovalent binding to the transferrin receptor. Theranostics, 7(2), 308–318. https://doi.org/10.7150/thno.17155
Jones, A. R., & Shusta, E. V. (2007). Blood–brain barrier transport of therapeutics via receptor-mediation. Pharmaceutical Research, 24(9), 1759–1771.
Kirschner, K. M. (2021). Reduce, replace, refine—Animal experiments. Acta Physiologica, 233(3). https://doi.org/10.1111/apha.13726
Linville, R. M., & Searson, P. C. (2021). Next ‑ generation in vitro blood – brain barrier models : benchmarking and improving model accuracy. Fluids and Barriers of the CNS, 18(1), 1–7. https://doi.org/10.1186/s12987-021-00291-y
Lundbäck, P., Lea, J. D., Sowinska, A., Ottosson, L., Fürst, C. M., Steen, J., Aulin, C., Clarke, J. I., Kipar, A., Klevenvall, L., Yang, H., Palmblad, K., Park, B. K., Tracey, K. J., Blom, A. M., Andersson, U., Antoine, D. J., & Erlandsson Harris, H. (2016). A novel high mobility group box 1 neutralizing chimeric antibody attenuates drug-induced liver injury and postinjury inflammation in mice. Hepatology, 64(5), 1699–1710. https://doi.org/10.1002/hep.28736
Marsh, E. W., Leopold, P. L., Jones, N. L., & Maxfield, F. R. (1995). Oligomerized transferrin receptors are selectively retained by a lumenal sorting signal in a long-lived endocytic recycling compartment. Journal of Cell Biology, 129(6), 1509–1522. https://doi.org/10.1083/jcb.129.6.1509
Mayle, K. M., Le, A. M., & Kamei, D. T. (2012). The intracellular trafficking pathway of transferrin. Biochimica et Biophysica Acta, 1820(3), 264–281. https://doi.org/10.1016/j.bbagen.2011.09.009
McCluskey, A., Daniel, J. A., Hadzic, G., Chau, N., Clayton, E. L., Mariana, A., Whiting, A., Gorgani, N. N., Lloyd, J., Quan, A., Moshkanbaryans, L., Krishnan, S., Perera, S., Chircop, M., von Kleist, L., Mcgeachie, A. B., Howes, M. T., Parton, R. G., Campbell, M., … Robinson, P. J. (2013). Building a better dynasore: The dyngo compounds potently inhibit dynamin and endocytosis. Traffic, 14(12), 1272–1289. https://doi.org/10.1111/tra.12119
Niewoehner, J., Bohrmann, B., Collin, L., Urich, E., Sade, H., Maier, P., Rueger, P., Stracke, J. O., Lau, W., Tissot, A. C., Loetscher, H., Ghosh, A., & Freskgård, P. O. (2014). Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle. Neuron, 81(1), 49–60. https://doi.org/10.1016/j.neuron.2013.10.061
Pardridge, W. M. (2012). Drug transport across the blood-brain barrier. Journal of Cerebral Blood Flow and Metabolism, 32(11), 1959–1972. https://doi.org/10.1038/jcbfm.2012.126
Raub, T. J., & Newton, C. R. (1991). Recycling kinetics and transcytosis of transferrin in primary cultures of bovine brain microvessel endothelial cells. Journal of Cellular Physiology, 149(1), 141–151. https://doi.org/10.1002/jcp.1041490118
Rofo, Fadi., Sandbaumhüter, F. A., Chourlia, Aikaterini., Metzendorf, N. G., Morrison, J. I., Syvänen, Stina., Andrén, P. E., Jansson, E. T., & Hultqvist, Greta. (2021). Wide-Ranging Effects on the Brain Proteome in a Transgenic Mouse Model of Alzheimer’s Disease following Treatment with a Brain-Targeting Somatostatin Peptide. ACS Chemical Neuroscience, 12(13), 2529–2541. https://doi.org/10.1021/acschemneuro.1c00303
Rofo, Fadi., Yilmaz, C. Ugur., Metzendorf, Nicole., Gustavsson, Tobias., Beretta, Chiara., Erlandsson, Anna., Sehlin, Dag., Syvänen, Stina., Nilsson, P., & Hultqvist, G. (2021). Enhanced neprilysin-mediated degradation of hippocampal Aβ42 with a somatostatin peptide that enters the brain. Theranostics, 11(2), 789–804. https://doi.org/10.7150/thno.50263
Romito, A., & Cobellis, G. (2016). Pluripotent stem cells: Current understanding and future directions. Stem Cells International, 2016(Icm). https://doi.org/10.1155/2016/9451492
Sade, H., Baumgartner, C., Hugenmatter, A., Moessner, E., Freskgård, P. O., & Niewoehner, J. (2014). A human blood-brain barrier transcytosis assay reveals antibody transcytosis influenced by pH-dependent receptor binding. PLoS ONE, 9(4). https://doi.org/10.1371/journal.pone.0096340
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012). NIH Image to ImageJ: 25 years of image analysis. Nature Methods, 9(7), 671–675. https://doi.org/10.1038/nmeth.2089
Simonneau, C., Duschmalé, M., Gavrilov, A., Brandenberg, N., Hoehnel, S., Ceroni, C., Lassalle, E., Kassianidou, E., Knoetgen, H., Niewoehner, J., & Villaseñor, R. (2021). Investigating receptor-mediated antibody transcytosis using blood–brain barrier organoid arrays. Fluids and Barriers of the CNS, 18(1), 1–17. https://doi.org/10.1186/s12987-021-00276-x
Stanimirovic, D. B., Sandhu, J. K., & Costain, W. J. (2018). Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood–Brain Barrier. BioDrugs, 32(6), 547–559. https://doi.org/10.1007/s40259-018-0309-y
Strazielle, N., & Ghersi-Egea, J.-F. (2016). Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier. Current Pharmaceutical Design, 22(35), 5463–5476. https://doi.org/10.2174/1381612822666160726112115
Vazin, T., & Freed, W. J. (2010). Human embryonic stem cells: derivation, culture, and differentiation: a review. Restorative Neurology and Neuroscience, 28(4), 589–603. https://doi.org/10.3233/RNN-2010-0543
Williams-Medina, A., Deblock, M., & Janigro, D. (2021). In vitro Models of the Blood–Brain Barrier: Tools in Translational Medicine. Frontiers in Medical Technology, 2(February), 1–20. https://doi.org/10.3389/fmedt.2020.623950
Zuchero, Y. J. Y., Chen, X., Bien-Ly, N., Bumbaca, D., Tong, R. K., Gao, X., Zhang, S., Hoyte, K., Luk, W., Huntley, M. A., Phu, L., Tan, C., Kallop, D., Weimer, R. M., Lu, Y., Kirkpatrick, D. S., Ernst, J. A., Chih, B., Dennis, M. S., & Watts, R. J. (2016). Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies. Neuron, 89(1), 70–82. https://doi.org/10.1016/j.neuron.2015.11.024